Table 1.
Patient characteristics
| Variables | Total number (%) |
|---|---|
| Gender | |
| Male | 100 (72.5) |
| Female | 38 (27.5) |
| Age, years [median (IQR)] | 60 (53–69) |
| Site | |
| Low | 43 (31.2) |
| Middle | 75 (54.3) |
| High | 20 (14.5) |
| Tumor size | |
| > 5 cm | 63 (45.7) |
| ≤ 5 cm | 75 (54.3) |
| cTNM | |
| II | 31 (22.5) |
| III | 107 (77.5) |
| ypTNM | |
| 0-I | 74 (53.6) |
| II-III | 64 (46.4) |
| Histopathology | |
| Well differentiation | 6 (4.7) |
| Moderate differentiation | 109 (84.5) |
| Poor differentiation | 14 (10.9) |
| LVI | |
| Positive | 8 (5.8) |
| Negative | 130 (94.2) |
| PNI | |
| Positve | 17 (12.3) |
| Negative | 121 (87.7) |
| Tumor deposits | |
| Positive | 20 (14.5) |
| Negative | 118 (85.5) |
| TRG | |
| 0–1 | 80 (58.0) |
| 2–3 | 58 (42.0) |
| LNH [median (IQR)] | 8.8 (5.0–12.0) |
| CEA [median (IQR)] | 3.5 (1.8–4.1) |
| FARI% [median (IQR)] | 7.7 (6.5–8.7) |
| PNI [median (IQR)] | 45.9 (43.2–48.5) |
| CFP | |
| Low | 95 (68.8) |
| High | 43 (31.2) |
IQR interquartile rangel, LVI lymphovascular invasion, PNI perineural invasion, TRG tumor regression grade, LHN lymph node harvest, CEA carcinoembryonic antigen, PNI prognostic nutrition index, FARI fibrinogen–Albumin Ratio Index, CFP CEA-FARI-PNI score